Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 298 participants.

Also called NCT05784051

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 298 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05784051
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT05784051. Randomized; no masking; primary purpose prevention. Start 2023-10-01 (anticipated); primary completion 2027-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS
Acronym
SUPPRESS
Condition
Premature Ventricular Contractions
Condition
Ventricular Dysfunction, Left
Intervention (Drug)
Experimental group
Intervention (Drug)
Control group
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)

Record details

Record id
cardio:ct-nct05784051
Content hash
248e5bdaaf821fb0d83fe4c68dca03a8250f3b50b1db071c62a508b5f8ede5e2